• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对人蛋白酶体具有更高选择性的肽硼酸SUB1抑制剂。

Peptidic Boronic Acid SUB1 Inhibitors with Improved Selectivity over Human Proteasome.

作者信息

Withers-Martinez Chrislaine, Lidumniece Elina, Hackett Fiona, Collins Christine R, Taha Zahie, Blackman Michael J, Jirgensons Aigars

机构信息

Malaria Biochemistry Laboratory, The Francis Crick Institute, London NW1 1AT, U.K.

Latvian Institute of Organic Synthesis, Riga LV-1006, Latvia.

出版信息

J Med Chem. 2024 Aug 8;67(15):13033-13055. doi: 10.1021/acs.jmedchem.4c01005. Epub 2024 Jul 25.

DOI:10.1021/acs.jmedchem.4c01005
PMID:39051854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7616463/
Abstract

subtilisin-like serine protease 1 (PfSUB1) is essential for egress of invasive merozoite forms of the parasite, rendering PfSUB1 an attractive antimalarial target. Here, we report studies aimed to improve drug-like properties of peptidic boronic acid PfSUB1 inhibitors including increased lipophilicity and selectivity over human proteasome (H20S). Structure-activity relationship investigations revealed that lipophilic P amino acid side chains as well as -capping groups were well tolerated in retaining PfSUB1 inhibitory potency. At the P position, replacing the methyl group with a carboxyethyl substituent led to boralactone PfSUB1 inhibitors with remarkably improved selectivity over H20S. Combining lipophilic end-capping groups with the boralactone reduced the selectivity over H20S. However, compound still showed >60-fold selectivity versus H20S and low nanomolar PfSUB1 inhibitory potency. Importantly, this compound inhibited the growth of a genetically modified line expressing reduced levels of PfSUB1 13-fold more efficiently compared to a wild-type parasite line.

摘要

枯草杆菌蛋白酶样丝氨酸蛋白酶1(PfSUB1)对于疟原虫侵袭性裂殖子形式的逸出至关重要,这使得PfSUB1成为一个有吸引力的抗疟靶点。在此,我们报告旨在改善肽硼酸PfSUB1抑制剂类药物特性的研究,包括提高亲脂性以及对人蛋白酶体(H20S)的选择性。构效关系研究表明,亲脂性的P氨基酸侧链以及封端基团在保留PfSUB1抑制活性方面具有良好的耐受性。在P位,用羧乙基取代基取代甲基可得到对H20S选择性显著提高的硼内酯PfSUB1抑制剂。将亲脂性封端基团与硼内酯结合会降低对H20S的选择性。然而,化合物 对H20S的选择性仍>60倍,且对PfSUB1具有低纳摩尔抑制活性。重要的是,与野生型寄生虫株相比,该化合物抑制表达水平降低的PfSUB1的基因改造株生长的效率高出13倍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/45206b4d4d73/EMS198616-f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/43eea04d6ec4/EMS198616-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/92631299ee55/EMS198616-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/c8500ce59e28/EMS198616-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/a2e0ec4833e9/EMS198616-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/4e3e1be99724/EMS198616-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/85fccc78f464/EMS198616-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/108ee0002beb/EMS198616-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/45206b4d4d73/EMS198616-f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/43eea04d6ec4/EMS198616-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/92631299ee55/EMS198616-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/c8500ce59e28/EMS198616-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/a2e0ec4833e9/EMS198616-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/4e3e1be99724/EMS198616-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/85fccc78f464/EMS198616-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/108ee0002beb/EMS198616-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f6/7616463/45206b4d4d73/EMS198616-f008.jpg

相似文献

1
Peptidic Boronic Acid SUB1 Inhibitors with Improved Selectivity over Human Proteasome.对人蛋白酶体具有更高选择性的肽硼酸SUB1抑制剂。
J Med Chem. 2024 Aug 8;67(15):13033-13055. doi: 10.1021/acs.jmedchem.4c01005. Epub 2024 Jul 25.
2
Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1.肽硼酸是疟原虫出芽丝氨酸蛋白酶 SUB1 的有效细胞穿透抑制剂。
Proc Natl Acad Sci U S A. 2021 May 18;118(20). doi: 10.1073/pnas.2022696118.
3
Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1.喹喔啉腙类化合物作为新型疟原虫丝氨酸蛋白酶 PfSUB1 的抑制剂。
Bioorg Med Chem Lett. 2012 Aug 15;22(16):5317-21. doi: 10.1016/j.bmcl.2012.06.023. Epub 2012 Jun 23.
4
Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in .共价大环蛋白酶体抑制剂减轻. 的耐药性。
ACS Infect Dis. 2023 Oct 13;9(10):2036-2047. doi: 10.1021/acsinfecdis.3c00310. Epub 2023 Sep 15.
5
Small phenolic inhibitors of PfATP6, a Plasmodium falciparum calcium ATPase, as prototype antimalarials.恶性疟原虫钙ATP酶PfATP6的小分子酚类抑制剂作为抗疟原型药物
Bioorg Med Chem. 2025 Nov 1;129:118342. doi: 10.1016/j.bmc.2025.118342. Epub 2025 Aug 7.
6
Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1.疟原虫药物靶点枯草杆菌蛋白酶样 SUB1 的肽 α-酮酰胺抑制剂的结构-活性关系和结合模式的研究进展。
Eur J Med Chem. 2024 Apr 5;269:116308. doi: 10.1016/j.ejmech.2024.116308. Epub 2024 Mar 11.
7
PfHDAC1 is an essential regulator of asexual proliferation and host cell invasion genes with a dynamic genomic occupancy responsive to artemisinin stress.PfHDAC1 是无性繁殖和宿主细胞入侵基因的必需调节因子,其基因组占据具有动态性,可响应青蒿素压力。
mBio. 2024 Jun 12;15(6):e0237723. doi: 10.1128/mbio.02377-23. Epub 2024 May 6.
8
Computational Analysis of Plasmodium falciparum DNA Damage Inducible Protein 1 (PfDdi1): Insights into Binding of Artemisinin and its Derivatives and Implications for Antimalarial Drug Design.恶性疟原虫DNA损伤诱导蛋白1(PfDdi1)的计算分析:青蒿素及其衍生物结合情况的深入研究及对抗疟药物设计的启示
Cell Biochem Biophys. 2025 Mar 20. doi: 10.1007/s12013-025-01709-2.
9
Rational design of the first difluorostatone-based PfSUB1 inhibitors.首个基于二氟司他酮的PfSUB1抑制剂的合理设计。
Bioorg Med Chem Lett. 2014 Aug 1;24(15):3582-6. doi: 10.1016/j.bmcl.2014.05.044. Epub 2014 May 23.
10
Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.疟原虫枯草溶菌素样蛋白酶 1(SUB1):对泛疟疾药物靶点的活性位点结构、特异性和功能的深入了解。
Int J Parasitol. 2012 May 15;42(6):597-612. doi: 10.1016/j.ijpara.2012.04.005. Epub 2012 Apr 27.

本文引用的文献

1
Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1.疟原虫药物靶点枯草杆菌蛋白酶样 SUB1 的肽 α-酮酰胺抑制剂的结构-活性关系和结合模式的研究进展。
Eur J Med Chem. 2024 Apr 5;269:116308. doi: 10.1016/j.ejmech.2024.116308. Epub 2024 Mar 11.
2
Emerging Drug Targets for Antimalarial Drug Discovery: Validation and Insights into Molecular Mechanisms of Function.抗疟药物发现的新兴药物靶点:功能的分子机制验证和见解。
J Med Chem. 2024 Jan 25;67(2):838-863. doi: 10.1021/acs.jmedchem.3c01828. Epub 2024 Jan 10.
3
Antimalarial drug discovery: progress and approaches.
抗疟药物发现:进展与方法。
Nat Rev Drug Discov. 2023 Oct;22(10):807-826. doi: 10.1038/s41573-023-00772-9. Epub 2023 Aug 31.
4
Macrocyclic Peptidomimetic Plasmepsin X Inhibitors with Potent and Antimalarial Activity.大环肽拟肽原虫 X 抑制剂具有强效抗疟活性。
J Med Chem. 2023 Aug 10;66(15):10658-10680. doi: 10.1021/acs.jmedchem.3c00812. Epub 2023 Jul 28.
5
Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.枯草杆菌蛋白酶样丝氨酸蛋白酶 1(SUB1)作为新兴的抗疟药物靶点:抑制剂发现的最新进展。
J Med Chem. 2022 Oct 13;65(19):12535-12545. doi: 10.1021/acs.jmedchem.2c01093. Epub 2022 Sep 22.
6
Evidence of Artemisinin-Resistant Malaria in Africa.非洲出现青蒿素抗药性疟疾。
N Engl J Med. 2021 Sep 23;385(13):1163-1171. doi: 10.1056/NEJMoa2101746.
7
Design of proteasome inhibitors with oral efficacy in vivo against and selectivity over the human proteasome.设计具有体内抗 和对人蛋白酶体选择性的口服功效的蛋白酶体抑制剂。
Proc Natl Acad Sci U S A. 2021 Sep 28;118(39). doi: 10.1073/pnas.2107213118.
8
Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1.肽硼酸是疟原虫出芽丝氨酸蛋白酶 SUB1 的有效细胞穿透抑制剂。
Proc Natl Acad Sci U S A. 2021 May 18;118(20). doi: 10.1073/pnas.2022696118.
9
Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized Mice.开发一种高选择性的恶性疟原虫蛋白酶体抑制剂,在人源化小鼠中具有抗疟活性。
Angew Chem Int Ed Engl. 2021 Apr 19;60(17):9279-9283. doi: 10.1002/anie.202015845. Epub 2021 Mar 11.
10
Redesigned TetR-Aptamer System To Control Gene Expression in Plasmodium falciparum.重新设计的 TetR-Aptamer 系统可控制疟原虫中的基因表达。
mSphere. 2020 Aug 12;5(4):e00457-20. doi: 10.1128/mSphere.00457-20.